Laboratory Information:
National Institute on Drug Abuse
6001 Executive Boulevard
Room 5213
Bethesda, MD 20892-9561
Website: http://www.nida.nih.gov/
Technology Transfer Website: http://www.nida.nih.gov/funding/TechTrans.html
Agency/Department: Dept. of Health and Human Services
Region: Mid-Atlantic
FLC Laboratory Representative:
Aida Klun
Phone: (301) 443-1122
Fax: (301) 443-2599
Email: ak102w@nih.gov
Background/History of the Laboratory:
Recent scientific advances have revolutionized
our understanding of drug abuse and addiction. The majority of
these advances, which have dramatic implications for how to best prevent and treat addiction, have been
supported by the National Institute on Drug Abuse (NIDA). NIDA supports most of the world's research
on the
health aspects of drug abuse and addiction. NIDA supported science addresses the most fundamental and
essential questions about drug abuse, ranging from the molecule to managed care, and from DNA to
community outreach research. NIDA is not only seizing upon unprecedented opportunities and technologies
to
further the understanding of how drugs of abuse affect the brain and behavior, but also working to ensure
the
rapid and effective transfer of scientific data to policy makers, drug abuse practitioners, other health
care
practitioners, and the general public. The NIDA web site is an important part of this effort. The scientific
knowledge that is generated through NIDA research is a critical element to improving the overall health
of the
Nation. Our goal is to ensure that science, not ideology or anecdote, forms the foundation for all of
our Nation's
drug abuse reduction efforts. NIDA was established in 1974, and in October 1992 it became part of the
National
Institutes of Health, Department of Health and Human Services. The Institute is organized into divisions
and
offices, each of which plays an important role in programs of drug abuse research.
Mission of the Laboratory:
NIDA's mission is to lead the Nation in
bringing the power of science to bear on drug abuse and addiction.
Technology Transfer Mechanisms:
- Clinical Trial Agreements (CTAs)
- Confidential Disclosure Agreements (CDAs)
- Cooperative Research and Development Agreements (CRADAs)
- Material Transfer Agreements
